Financial Performance
5Y price score: (8)
The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.
A score of 100 indicates that the stock did as well as the S&P 500 Index.
A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.
10Y return: 240%
%
ㅤ
By default your notes are visible only to you.
255.9
52-week range
461.6
Your model inputs
Your fair value & Margin of safety
To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.
Forecast:
Valuation
Free Cash Flow Yield
6.3 %
Dividend Yield TTM
2.3 %
Market cap $
$ 360,322
Price / Earnings TTM
22.9
Price / Book TTM
3.5
PEG TTM
(1.6)
Earnings growth and return
LTM
5YR
10YR
Total return (price & dividends)
15 %
2.2 %
240 %
Free cash flow per share growth
(14.7) %
(15.6) %
108.7 %
Earnings per share growth
76.1 %
(17.5) %
120.1 %
Founded: 1,977
Employees: 400,000
Business Summary:
Q&A
Contribute
By providing well-researched and detailed answer you increase your chance of becoming Top Contributor. TopFunds is free for all top contributors. Learn more
Latest Earnings Call Takeaways
2026 Q3 (Oct 13, 2026)
1) Strategy & Leadership
- UnitedHealth Group aims for sustainable growth within a long-term target growth range of 13%-16%.
- The company is modernizing its enterprise with simplified processes and AI-enabled capabilities to enhance care quality and reduce costs.
- The reimagined United Health Foundation has committed $1 billion to address significant U.S. health challenges, including rural health and behavioral health.
- Leadership emphasizes the importance of adapting to a dynamic healthcare environment and improving relationships with stakeholders.
2) Financial & Segment Results
- Q3 2026 revenue reached $113 billion, with adjusted EPS of $4.69, up from $2.92 YoY.
- The consolidated medical care ratio improved to 88.4% from 89.9% last year.
- Medicare Advantage margins are expected to be near the top end of the 2%-4% range for 2026, driven by effective cost management and product offerings.
- The commercial business is stabilizing, with costs exceeding initial expectations of 11% due to high-cost specialty drugs and regulatory impacts.
3) Operational & Product Plans
- UnitedHealthcare is enhancing its Medicare and Medicaid offerings, focusing on high-value plans and integrated care.
- AI initiatives have improved operational efficiency, such as reducing chart review time by 33% and appeal cycle times by 26%.
- Optum Health reported a 27% increase in online self-scheduling and a 10% rise in home health visits YoY.
- The company is expanding its pharmacy services and integrating them more closely with medical care to improve patient outcomes.
4) Guidance & Outlook / Investor Angle
- The updated adjusted EPS guidance for 2026 is at least $20.50, reflecting strong performance and ongoing investments.
- The company anticipates a balanced set of tailwinds and headwinds for 2027, with focus on sustainable organic growth and improving Medicare fundamentals.
- Analysts may be underestimating growth opportunities for 2027, with the lower end of the long-term growth rate seen as a reasonable starting point.
- Continued investments in technology and modernization are expected to drive future growth and improve margins.
5) Missing Information
- The transcript lacks specific figures for certain segments and detailed guidance on 2027 membership growth and margin expectations across all business lines.
Bottom line: UnitedHealth Group is positioned for strong growth driven by strategic modernization, effective cost management, and a focus on integrated care, making it an attractive investment for shareholders looking for sustainable long-term returns.
Annual Reports, Presentations And IR Contacts
Go to the websiteUnitedHealth Group — Financial Overview, Stock Price, Market Cap
UnitedHealth Group is a company. Founded in 1977. As of October 19, 2026, the company's market capitalization is $360321560850 with a current stock price of $401.43.